303
Participants
Start Date
September 30, 1999
Primary Completion Date
December 31, 2002
Study Completion Date
December 31, 2002
positron emission tomography
radionuclide imaging
fludeoxyglucose F 18
Memorial Sloan-Kettering Cancer Center, New York
Western Pennsylvania Cancer Institute, Pittsburgh
Jameson Memorial Hospital, New Castle
Duke Comprehensive Cancer Center, Durham
Morton Plant Mease Health Care, Clearwater
William Beaumont Hospital, Royal Oak
Lutheran General Hospital, Park Ridge
Barnes-Jewish Hospital, St Louis
Latter Day Saints Hospital, Salt Lake City
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles
UCSF Cancer Center and Cancer Research Institute, San Francisco
Lakeland Regional Medical Center, Lakeland
University of Chicago Cancer Research Center, Chicago
Indiana University Cancer Center, Indianapolis
Holden Comprehensive Cancer Center, Iowa City
Veterans Affairs Medical Center - Iowa City, Iowa City
Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore
Massachusetts General Hospital Cancer Center, Boston
Mount Sinai School of Medicine, New York
Westmoreland Hospital, Greensburg
Allegheny General Hospital, Pittsburgh
Medical University of South Carolina, Charleston
Massey Cancer Center, Richmond
National Cancer Institute (NCI)
NIH
Alliance for Clinical Trials in Oncology
OTHER